BLFS
Price
$27.36
Change
+$1.25 (+4.79%)
Updated
Dec 20, 04:59 PM (EDT)
81 days until earnings call
NEO
Price
$16.41
Change
+$0.01 (+0.06%)
Updated
Dec 20 closing price
65 days until earnings call
Ad is loading...

BLFS vs NEO

Header iconBLFS vs NEO Comparison
Open Charts BLFS vs NEOBanner chart's image
BioLife Solutions
Price$27.36
Change+$1.25 (+4.79%)
Volume$7.19K
CapitalizationN/A
NeoGenomics
Price$16.41
Change+$0.01 (+0.06%)
Volume$3.31M
CapitalizationN/A
BLFS vs NEO Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. NEO commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and NEO is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (BLFS: $27.39 vs. NEO: $16.41)
Brand notoriety: BLFS and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 245% vs. NEO: 445%
Market capitalization -- BLFS: $810.87M vs. NEO: $2.01B
BLFS [@Medical Specialties] is valued at $810.87M. NEO’s [@Medical Specialties] market capitalization is $2.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 6 TA indicator(s) are bullish while NEO’s TA Score has 5 bullish TA indicator(s).

  • BLFS’s TA Score: 6 bullish, 3 bearish.
  • NEO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BLFS is a better buy in the short-term than NEO.

Price Growth

BLFS (@Medical Specialties) experienced а +2.58% price change this week, while NEO (@Medical Specialties) price change was -7.45% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

BLFS is expected to report earnings on Mar 13, 2025.

NEO is expected to report earnings on Feb 25, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEO($2.01B) has a higher market cap than BLFS($811M). BLFS has higher P/E ratio than NEO: BLFS (238.10) vs NEO (49.50). BLFS YTD gains are higher at: 68.554 vs. NEO (1.422). NEO has higher annual earnings (EBITDA): -17.61M vs. BLFS (-45.24M). NEO has more cash in the bank: 415M vs. BLFS (51.7M). BLFS has less debt than NEO: BLFS (42.7M) vs NEO (612M). NEO has higher revenues than BLFS: NEO (592M) vs BLFS (143M).
BLFSNEOBLFS / NEO
Capitalization811M2.01B40%
EBITDA-45.24M-17.61M257%
Gain YTD68.5541.4224,823%
P/E Ratio238.1049.50481%
Revenue143M592M24%
Total Cash51.7M415M12%
Total Debt42.7M612M7%
FUNDAMENTALS RATINGS
BLFS vs NEO: Fundamental Ratings
BLFS
NEO
OUTLOOK RATING
1..100
9450
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
9392
PRICE GROWTH RATING
1..100
3948
P/E GROWTH RATING
1..100
14100
SEASONALITY SCORE
1..100
20n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (71) in the Medical Or Nursing Services industry is in the same range as BLFS (95) in the Medical Specialties industry. This means that NEO’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (74) in the Medical Specialties industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that BLFS’s stock grew similarly to NEO’s over the last 12 months.

NEO's SMR Rating (92) in the Medical Or Nursing Services industry is in the same range as BLFS (93) in the Medical Specialties industry. This means that NEO’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Price Growth Rating (39) in the Medical Specialties industry is in the same range as NEO (48) in the Medical Or Nursing Services industry. This means that BLFS’s stock grew similarly to NEO’s over the last 12 months.

BLFS's P/E Growth Rating (14) in the Medical Specialties industry is significantly better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that BLFS’s stock grew significantly faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSNEO
RSI
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 13 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
73%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FISPX7.910.09
+1.15%
Federated Hermes Max-Cap Index IS
HAIAX53.280.52
+0.99%
Hartford Core Equity A
GTSFX39.470.34
+0.87%
Invesco Small Cap Growth R6
MECZX46.990.33
+0.71%
AMG GW&K International Small Cap Z
CIHEX17.420.09
+0.52%
Calamos Hedged Equity I

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with MASS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+4.90%
MASS - BLFS
50%
Loosely correlated
+6.19%
RGEN - BLFS
49%
Loosely correlated
-1.42%
VCYT - BLFS
48%
Loosely correlated
+4.66%
AZTA - BLFS
48%
Loosely correlated
+1.88%
RDNT - BLFS
44%
Loosely correlated
+1.85%
More